Clinical Trials Directory

Trials / Completed

CompletedNCT00517621

Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire

A Multicenter Prospective Phase II Study Evaluating Peripheral Neurotoxicity by Using FACT-GOG/NTX Questionnaire in Patients With Ovarian Cancer in Relapse Treated by Paclitaxel +/- EPO. Validation of a French Version of This Questionnaire

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
ARCAGY/ GINECO GROUP · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

validation of a french version of FACT-GOG/NTX and using this questionnaire to evaluate the incidence of the peripheral neurotoxicity in patients treated for ovarian cancer with paclitaxel associated or not with EPO.

Conditions

Interventions

TypeNameDescription
DRUGPaclitaxel
DRUGEPO

Timeline

Start date
2006-02-01
Primary completion
2010-09-01
Completion
2010-10-01
First posted
2007-08-17
Last updated
2011-02-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00517621. Inclusion in this directory is not an endorsement.